| An SI Board Since November 2012 |
| Posts |
SubjectMarks |
Bans |
Symbol |
| 0 |
0 |
0
|
ARNA |
|
Aetna's recent decision to cover prescriptions for Arena's obesity drug Belviq is not an isolated event. Two important policy shifts at the federal level paved the way, and the policy shifts also bode well for more private insurance, Medicare and Medicaid coverage of prescription weight-loss drugs, including Belviq and Vivus, Inc.'s Qsymia. The shift in prescription coverage, a logical way to cut massive health costs caused by obesity-related disease and disability, is made possible by the FDA's approval of Belviq and Qsymia this summer.
The full story is at: sandiegobiotechnology.com
|
|
|
